- Home
- IMNM vs HSII Comparison
IMNM vs HSII Comparison
Compare IMNM & HSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- HSII
- Stock Information
- Founded
- IMNM 2006
- HSII 1953
- Country
- IMNM United States
- HSII United States
- Employees
- IMNM N/A
- HSII N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- HSII Diversified Commercial Services
- Sector
- IMNM Health Care
- HSII Consumer Discretionary
- Exchange
- IMNM Nasdaq
- HSII Nasdaq
- Market Cap
- IMNM 1.2B
- HSII 1.0B
- IPO Year
- IMNM 2020
- HSII 1999
- Fundamental
- Price
- IMNM $16.39
- HSII $58.39
- Analyst Decision
- IMNM Strong Buy
- HSII Buy
- Analyst Count
- IMNM 9
- HSII 2
- Target Price
- IMNM $24.89
- HSII $57.50
- AVG Volume (30 Days)
- IMNM 1.3M
- HSII 511.1K
- Earning Date
- IMNM 11-12-2025
- HSII 10-20-2025
- Dividend Yield
- IMNM N/A
- HSII 1.03%
- EPS Growth
- IMNM N/A
- HSII N/A
- EPS
- IMNM N/A
- HSII 1.60
- Revenue
- IMNM $12,589,000.00
- HSII $1,155,576,000.00
- Revenue This Year
- IMNM N/A
- HSII $10.87
- Revenue Next Year
- IMNM $85.68
- HSII $1.89
- P/E Ratio
- IMNM N/A
- HSII $36.42
- Revenue Growth
- IMNM 16.74
- HSII 9.00
- 52 Week Low
- IMNM $5.15
- HSII $36.87
- 52 Week High
- IMNM $17.32
- HSII $58.50
- Technical
- Relative Strength Index (RSI)
- IMNM 65.16
- HSII 76.37
- Support Level
- IMNM $15.35
- HSII $58.23
- Resistance Level
- IMNM $17.21
- HSII $58.31
- Average True Range (ATR)
- IMNM 1.14
- HSII 0.14
- MACD
- IMNM -0.01
- HSII -0.18
- Stochastic Oscillator
- IMNM 75.79
- HSII 76.60
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About HSII Heidrick & Struggles International Inc.
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments include the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.